Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-20

Clinical Trial Update: Study to Evaluate Primaquine for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in Children [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating primaquine for radical cure of uncomplicated Plasmodium vivax malaria in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Primaquine (primaquine)

Snippet

Sponsor: Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | Conditions: Malaria, Vivax | Phase 2 | Status: COMPLETED